Top Stories
Top Stories
Wires

FDA - WARNING LETTER IDENTIFIES SEVERAL STATEMENTS, INCLUDING STATEMENTS DISCUSSED IN TESTIMONY FROM A JULY 2019 CONGRESSIONAL HEARING ON JUUL